| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/INTIMM/14.4.367 |
| P698 | PubMed publication ID | 11934873 |
| P2093 | author name string | Jonathan Cebon | |
| Eugene Maraskovsky | |||
| Ken Shortman | |||
| Tracey Toy | |||
| Thomas Luft | |||
| Hubertus Hochrein | |||
| Kelly-Anne Masterman | |||
| Charlie Maliszewski | |||
| Petra Luetjens | |||
| Mark Rizkalla | |||
| P2860 | cites work | CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells | Q24310570 |
| Reduction of atherosclerosis in mice by inhibition of CD40 signalling | Q24316540 | ||
| Selective expression of an interleukin-12 receptor component by human T helper 1 cells | Q24670175 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses | Q33771205 | ||
| Natural adjuvants: endogenous activators of dendritic cells | Q33878894 | ||
| Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection | Q35958851 | ||
| Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis | Q36028683 | ||
| Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. | Q36368488 | ||
| Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells | Q36368860 | ||
| Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor | Q39760201 | ||
| Exogenous peptides presented by transporter associated with antigen processing (TAP)-deficient and TAP-competent cells: intracellular loading and kinetics of presentation | Q40785567 | ||
| IFN-alpha-expressing tumor cells enhance generation and promote survival of tumor-specific CTLs | Q40908112 | ||
| Role of viruses in the loss of tolerance to self-antigens and in autoimmune diseases | Q40953474 | ||
| Production of interferon-alpha/beta by murine dendritic cell lines stimulated by virus and bacteria | Q41088789 | ||
| The pathogenesis of postinfectious myocarditis | Q41114703 | ||
| Immune defence in mice lacking type I and/or type II interferon receptors | Q41126086 | ||
| Viral induction of autoimmunity: mechanisms and examples in hepatology | Q41681581 | ||
| Natural interferon alpha/beta-producing cells link innate and adaptive immunity | Q41748252 | ||
| Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production | Q42079617 | ||
| Mobilizing dendritic cells for tolerance, priming, and chronic inflammation | Q42576422 | ||
| Will the making of plasmacytoid dendritic cells in vitro help unravel their mysteries? | Q42972756 | ||
| Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C. | Q42988942 | ||
| Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a | Q43039967 | ||
| Splenic marginal metallophilic macrophages and marginal zone macrophages are the major interferon-alpha/beta producers in mice upon intravenous challenge with herpes simplex virus | Q45749828 | ||
| Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon | Q57275922 | ||
| Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-α | Q57791171 | ||
| P433 | issue | 4 | |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 367-380 | |
| P577 | publication date | 2002-04-01 | |
| P1433 | published in | International Immunology | Q15710043 |
| P1476 | title | IFN-alpha enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells. | |
| P478 | volume | 14 |
| Q47841318 | Addition of interferon-alpha to a standard maturation cocktail induces CD38 up-regulation and increases dendritic cell function. |
| Q64045773 | An unusual case of Erdheim-Chester disease with features of Langerhans cell histiocytosis |
| Q93368983 | Co-signaling receptors regulate T-cell plasticity and immune tolerance |
| Q40416524 | Dendritic cell therapy in combination with interferon-alpha for the treatment of metastatic renal cell carcinoma |
| Q35597117 | Dendritic-cell control of pathogen-driven T-cell polarization |
| Q58460058 | Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN- / on antigen cross-presentation |
| Q79635270 | Evaluation of CD86/CD28 and CD40/CD154 pathways in regulating monocyte-derived CD80 expression during their interaction with allogeneic endothelium |
| Q40558369 | Functional repertoire of dendritic cells generated in granulocyte macrophage-colony stimulating factor and interferon-alpha |
| Q33535818 | Gene expression profiles identify inflammatory signatures in dendritic cells |
| Q37173478 | Generation in vivo of peptide-specific cytotoxic T cells and presence of regulatory T cells during vaccination with hTERT (class I and II) peptide-pulsed DCs. |
| Q35967042 | Immunological aspects of head and neck cancer: biology, pathophysiology and therapeutic mechanisms. |
| Q58652034 | Immunotherapy for renal cell carcinoma |
| Q39954409 | Impact of alpha interferon and ribavirin on the function of maturing dendritic cells |
| Q43037738 | Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection |
| Q39297697 | Interferon-alpha and viral triggers promote functional maturation of human monocyte-derived dendritic cells |
| Q40349921 | Interferon-alpha2a is sufficient for promoting dendritic cell immunogenicity |
| Q37853631 | Interferon-α in the generation of monocyte-derived dendritic cells: recent advances and implications for dermatology |
| Q36108089 | Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence? |
| Q34146882 | MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity |
| Q41968893 | Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration. |
| Q79750884 | Modification of TLR-induced activation of human dendritic cells by type I IFN: synergistic interaction with TLR4 but not TLR3 agonists |
| Q37719756 | Monocyte activation by interferon α is associated with failure to achieve a sustained virologic response after treatment for hepatitis C virus infection |
| Q61811446 | Multiplexed enrichment and genomic profiling of peripheral blood cells reveal subset-specific immune signatures |
| Q58883557 | NADPH oxidase of human dendritic cells: Role inCandida albicans killing and regulation by interferons, dectin-1 and CD206 |
| Q61736987 | Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells |
| Q36845814 | Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells |
| Q38225118 | Oncogene-induced senescence as a new mechanism of disease: the paradigm of erdheim-chester disease |
| Q27014714 | Overlapping, additive and counterregulatory effects of type II and I interferons on myeloid dendritic cell functions |
| Q81152793 | Preparation of apoptotic tumor cells with replication-incompetent HSV augments the efficacy of dendritic cell vaccines |
| Q33262643 | Proteasomal chymotrypsin-like peptidase activity is required for essential functions of human monocyte-derived dendritic cells |
| Q35875298 | Recent areas of development for dendritic cell vaccines. |
| Q40447746 | Regulation of dendritic cell interleukin-12 secretion by tumour cell necrosis. |
| Q56775473 | Role of natural interferon-producing cells and T lymphocytes in porcine monocyte-derived dendritic cell maturation |
| Q27023059 | Success of antiviral therapy in chronic hepatitis C infection relates to functional status of myeloid dendritic cells |
| Q24321466 | Survival and migration of human dendritic cells are regulated by an IFN-alpha-inducible Axl/Gas6 pathway |
| Q58234774 | TLR-mediated STAT3 and ERK activation controls IL-10 secretion by human B cells |
| Q37123459 | Targeting intracellular signaling: a novel approach to vaccination. |
| Q91423531 | The IL-12-STAT4 axis in the pathogenesis of human systemic lupus erythematosus |
| Q37776696 | The dangerous liaison between iNKT cells and dendritic cells: does it prevent or promote autoimmune diseases? |
| Q35587022 | Total chemical synthesis of human interferon alpha-2b via native chemical ligation |
| Q39982625 | Tumour-mediated disruption of dendritic cell function: inhibiting the MEK1/2-p44/42 axis restores IL-12 production and Th1-generation. |
| Q42568916 | Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing |
| Q61863501 | Type I IFNs differentially modulate IL-12p70 production by human dendritic cells depending on the maturation status of the cells and counteract IFN-γ-mediated signaling |
| Q37728235 | Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists |
| Q38780088 | Type I and III IFNs Produced by Plasmacytoid Dendritic Cells in Response to a Member of the Flaviviridae Suppress Cellular Immune Responses. |
| Q84347520 | Type I and III interferons enhance IL-10R expression on human monocytes and macrophages, resulting in IL-10-mediated suppression of TLR-induced IL-12 |
| Q35752839 | Type I interferon as a link between innate and adaptive immunity through dendritic cell stimulation |
| Q35088161 | Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl-pentadecane (pristane) |
| Q38215320 | Type I interferons as regulators of human antigen presenting cell functions. |
| Q36734035 | Understanding HSV-1 entry glycoproteins. |
| Q38808121 | Vaccine-Induced Antibody Responses Prevent the Induction of Interferon Type I Responses Upon a Homotypic Live Virus Challenge |
Search more.